CN103341113A - Chinese medicine composition for treating chronic gastritis - Google Patents
Chinese medicine composition for treating chronic gastritis Download PDFInfo
- Publication number
- CN103341113A CN103341113A CN2013102611683A CN201310261168A CN103341113A CN 103341113 A CN103341113 A CN 103341113A CN 2013102611683 A CN2013102611683 A CN 2013102611683A CN 201310261168 A CN201310261168 A CN 201310261168A CN 103341113 A CN103341113 A CN 103341113A
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- chinese medicine
- radix
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 51
- 208000007882 Gastritis Diseases 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 title claims abstract description 28
- 208000023652 chronic gastritis Diseases 0.000 title claims abstract description 25
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 241000218176 Corydalis Species 0.000 claims abstract description 11
- 241001522129 Pinellia Species 0.000 claims abstract description 3
- 241000756943 Codonopsis Species 0.000 claims description 10
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 10
- 235000005903 Dioscorea Nutrition 0.000 claims description 2
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 2
- 241000545442 Radix Species 0.000 claims description 2
- 241000238370 Sepia Species 0.000 claims description 2
- 235000004879 dioscorea Nutrition 0.000 claims description 2
- 241000234273 Dioscorea Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 29
- 210000000952 spleen Anatomy 0.000 abstract description 12
- 210000002784 stomach Anatomy 0.000 abstract description 10
- 230000001105 regulatory effect Effects 0.000 abstract description 7
- 210000004072 lung Anatomy 0.000 abstract description 6
- 210000003734 kidney Anatomy 0.000 abstract description 5
- 230000003014 reinforcing effect Effects 0.000 abstract description 5
- 238000005728 strengthening Methods 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 2
- 230000008961 swelling Effects 0.000 abstract description 2
- 235000008671 Calycanthus floridus Nutrition 0.000 abstract 1
- 235000008670 Calycanthus occidentalis Nutrition 0.000 abstract 1
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 244000116484 Inula helenium Species 0.000 abstract 1
- 235000002598 Inula helenium Nutrition 0.000 abstract 1
- 241000234435 Lilium Species 0.000 abstract 1
- 244000148992 Lindera benzoin Species 0.000 abstract 1
- 235000004520 Lindera benzoin Nutrition 0.000 abstract 1
- 235000008262 Lindera benzoin var. benzoin Nutrition 0.000 abstract 1
- 241000218378 Magnolia Species 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 240000004980 Rheum officinale Species 0.000 abstract 1
- 235000008081 Rheum officinale Nutrition 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 9
- 210000004877 mucosa Anatomy 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 201000006549 dyspepsia Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 238000009499 grossing Methods 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010067171 Regurgitation Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 210000004211 gastric acid Anatomy 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 210000004907 gland Anatomy 0.000 description 3
- 208000024798 heartburn Diseases 0.000 description 3
- 230000001314 paroxysmal effect Effects 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 210000004203 pyloric antrum Anatomy 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 102100021022 Gastrin Human genes 0.000 description 2
- 108010052343 Gastrins Proteins 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010054949 Metaplasia Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 2
- 208000037976 chronic inflammation Diseases 0.000 description 2
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 230000015689 metaplastic ossification Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 208000004300 Atrophic Gastritis Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 244000281702 Dioscorea villosa Species 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 208000036495 Gastritis atrophic Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 201000010927 Mucositis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010046274 Upper gastrointestinal haemorrhage Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000008720 membrane thickening Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000001711 oxyntic cell Anatomy 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicine composition for treating chronic gastritis. The Chinese medicine composition comprises the following Chinese medicine raw materials in parts by weight: 10-40 parts of codonopsis pilosula, 10-30 parts of poria cocos, 10-40 parts of rhizoma atractylodis macrocephalae, 5-15 parts of fructus amomi, 5-15 parts of rhizoma cyperi, 5-15 parts of rheum officinale, 10-30 parts of cuttlebone, 5-15 parts of the root of three-nerved spicebush, 10-20 parts of fructus aurantii, 10-20 parts of fingered citron, 20-40 parts of lily, 5-15 parts of platycodon grandiflorum, 10-30 parts of dandelion, 5-15 parts of magnolia obavata, 10-40 parts of Chinese yam, 10-30 parts of rhizoma corydalis, 5-15 parts of pinellia ternate, 5-15 parts of dried tangerine or orange peel, 5-10 parts of liquorice and 5-15 parts of elecampane. The Chinese medicine composition has the effects of relieving the liver, regulating the qi, strengthening the spleen, tonifying the lung, reinforcing the stomach, tonifying the kidney, relieving sluggish and eliminating swelling, and is remarkable in effect on treating chronic gastritis and reliable in function, and the ingredients of the Chinese medicine composition is wide in source, simple and convenient to prepare and free of toxic and side effects.
Description
Technical field
The present invention relates to a kind of medicinal preparation of not determining structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of chronic gastritis.
Background technology
Chronic gastritis is the gastric mucosa inflammation.Modal is chronic superficial gastritis and chronic atrophic gastritis.Its main clinical manifestation is loss of appetite, epigastric discomfort and dull pain, belch, pantothenic acid, feel sick, vomiting etc.The morbidity of chronic gastritis may be relevant with following factor: the anti-stream of the sequel of acute gastritis, irritable food and medicine, duodenal juice, immune factor, infective agent etc.At present, treat chronic gastritis clinically and use antibiotics more, have the deficiency of curing the symptoms, not the disease.
Chronic gastritis belongs to sick categories such as Chinese medicine " gastric abscess ", " feeling of fullness ", " acid regurgitation ", " noisy ", " indigestion and loss of appetite ".
The traditional Chinese medical science thinks that chronic gastritis is many because feelings will is unsuccessful for a long time, eating and drinking without temperance, and work and rest is not normal, causes depression of liver-QI, dysfunction of the spleen in transportation, gastral cavilty is become estranged, and with the passing of time middle gas loses empty, thereby causes all symptoms.
According to theory of Chinese medical science, at the pathogeny of chronic gastritis, be the rule for the treatment of with liver-smoothing, qi-regulating, invigorating spleen and reinforcing stomach, dyspepsia and intestinal stasis relieving, carry out dialectical composition of prescription, to reach the purpose for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
Have the deficiency of curing the symptoms, not the disease in order to overcome the treatment of antibiotics in prior art chronic gastritis, the invention provides a kind ofly prepare conveniently, the medicine source is wide, cost is low, the Chinese medicine composition of evident in efficacy, reliable effect, the treatment chronic gastritis that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of chronic gastritis is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: Radix Codonopsis 10-40 part, Poria 10-30 part, Rhizoma Atractylodis Macrocephalae 10-40 part, Fructus Amomi 5-15 part, Rhizoma Cyperi 5-15 part, Radix Et Rhizoma Rhei 5-15 part, Endoconcha Sepiae 10-30 part, Radix Linderae 5-15 part, Fructus Aurantii 10-20 part, Fructus Citri Sarcodactylis 10-20 part, Bulbus Lilii 20-40 part, Radix Platycodonis 5-15 part, Herba Taraxaci 10-30 part, Cortex Magnoliae Officinalis 5-15 part, Rhizoma Dioscoreae 10-40 part, Rhizoma Corydalis 10-30 part, Rhizoma Pinelliae 5-15 part, Pericarpium Citri Reticulatae 5-15 part, Radix Glycyrrhizae 5-10 part and Radix Aucklandiae 5-15 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of chronic gastritis is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: 10 parts of 30 parts of Radix Codonopsis, 20 parts in Poria, 30 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of Fructus Amomis, 10 parts of Rhizoma Cyperis, 10 parts of Radix Et Rhizoma Rhei, 20 parts of Endoconcha Sepiaes, 10 parts of the Radixs Linderae, 15 parts of Fructus Aurantiis, 15 parts of Fructus Citri Sarcodactylis, 30 parts of Bulbus Liliies, 10 parts of Radix Platycodoniss, 20 parts of Herba Taraxacis, 10 parts of Cortex Magnoliae Officinalis, 30 parts of Rhizoma Dioscoreaes, 20 parts of Rhizoma Corydalis, 10 parts of the Rhizoma Pinelliaes, 10 parts of Pericarpium Citri Reticulataes, 6 parts in Radix Glycyrrhizae and the Radix Aucklandiae.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In the Chinese medicine composition of the present invention: Radix Codonopsis has the effect of invigorating the spleen and replenishing QI, spleen invigorating lung benefiting; Poria has the effect of promoting diuresis to eliminate damp pathogen, strengthening the spleen stomach function regulating, mind tranquilizing and the heart calming; The Rhizoma Atractylodis Macrocephalae has invigorating the spleen and benefiting QI, dampness diuretic, the antiabortive effect of hidroschesis; Fructus Amomi has the removing dampness appetizing, and is warming spleen and stopping diarrha, the antiabortive effect of regulating the flow of vital energy; Rhizoma Cyperi has the effect of the resolving depression of regulating the flow of vital energy, menstruction regulating and pain relieving; Rhizoma Cyperi has the effect of liver-smoothing, qi-regulating, resolving depression pain relieving; Radix Et Rhizoma Rhei has the effect of pathogenic fire purging removing food stagnancy, heat-clearing and toxic substances removing, cooling blood for hemostasis, blood stasis dispelling cough-relieving; Endoconcha Sepiae has the effect that astringing to arrest bleeding, treating spontaneous emission and leukorrhagia, relieving gastric hyperacidity to alleviate stomachache, removing dampness are held back skin ulcer; The Radix Linderae has the effect of promoting the circulation of QI to relieve pain, warming kidney for dispelling cold; Fructus Aurantii has the effect of regulating the flow of QI to ease the stomach, the stagnant relieving distension of row; Fructus Citri Sarcodactylis has the effect of liver-smoothing, qi-regulating and stomach and alleviating pain; Bulbus Lilii has the effect of nourishing YIN and moistening the lung, clearing away heart-fire for tranquillization, nourishing essence-blood; Radix Platycodonis has lung qi dispersing and eliminates the phlegm, fosters the spirit of nobility and enrich blood, sharp the five internal organs, mend the effect of five kinds of over strain; Herba Taraxaci has the effect of heat-clearing and toxic substances removing, dispersing swelling and dissipating binds; Cortex Magnoliae Officinalis has the circulation of qi promoting removing food stagnancy, and dampness is except expiring the effect of lowering the adverse QI to relieve asthma; Rhizoma Dioscoreae has strengthening the spleen and tonifying the lung, stomach reinforcing the kidney invigorating, the benefit of reinforcing the kidney essence, hearing-improing and eyesight improving, help the five internal organs, bone and muscle strengthening, grow that will is calmed the nerves, effect of prolonging life; Rhizoma Corydalis has the effect of promoting blood circulation to remove blood stasis, promoting the circulation of QI pain relieving; The Rhizoma Pinelliae has drying dampness to eliminate phlegm, the effect of stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass; Pericarpium Citri Reticulatae has the effect of diuretic, drying dampness to eliminate phlegm in regulating qi-flowing for strengthening spleen, the accent; The Radix Aucklandiae has the effect of intestinal stasis relieving in promoting the circulation of QI to relieve pain, the accent; Radix Glycyrrhizae has the effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription.Drug component in the present composition is through dialectical compatibility, complements each other using, and has synergism, plays the stagnate effect of relieving distension of liver-smoothing, qi-regulating, spleen invigorating lung benefiting, stomach reinforcing the kidney invigorating, row altogether, chronic gastritis reached the purpose for the treatment of both the principal and secondary aspects of a disease.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, the medicine source is wide, cost is low.It follows the prescription principle of medication of the traditional Chinese medical science, and various component drug adopt the usefulness that is decocted in water for oral dose.Through the clinical practice checking, it is evident in efficacy, reliable effect, and the property of medicine is gentle, toxic and side effects do not occur, total effective rate 90%, cure rate reaches 60%.
The specific embodiment
The present invention will be further described below in conjunction with embodiment.
Embodiment 1
A kind of Chinese medicine composition for the treatment of chronic gastritis, its raw material of Chinese medicine and weight proportion are: Radix Codonopsis 30g, Poria 20g, Rhizoma Atractylodis Macrocephalae 30g, Fructus Amomi 10g, Rhizoma Cyperi 10g, Radix Et Rhizoma Rhei 10g, Endoconcha Sepiae 20g, Radix Linderae 10g, Fructus Aurantii 15g, Fructus Citri Sarcodactylis 15g, Bulbus Lilii 30g, Radix Platycodonis 10g, Herba Taraxaci 20g, Cortex Magnoliae Officinalis 10g, Rhizoma Dioscoreae 30g, Rhizoma Corydalis 20g, Rhizoma Pinelliae 10g, Pericarpium Citri Reticulatae 10g, Radix Glycyrrhizae 6g and Radix Aucklandiae 10g.
Embodiment 2
A kind of Chinese medicine composition for the treatment of chronic gastritis, its raw material of Chinese medicine and weight proportion are: Radix Codonopsis 10g, Poria 30g, Rhizoma Atractylodis Macrocephalae 10g, Fructus Amomi 15g, Rhizoma Cyperi 5g, Radix Et Rhizoma Rhei 15g, Endoconcha Sepiae 10g, Radix Linderae 15g, Fructus Aurantii 10g, Fructus Citri Sarcodactylis 10g, Bulbus Lilii 40g, Radix Platycodonis 5g, Herba Taraxaci 30g, Cortex Magnoliae Officinalis 5g, Rhizoma Dioscoreae 40g, Rhizoma Corydalis 10g, Rhizoma Pinelliae 15g, Pericarpium Citri Reticulatae 5g, Radix Glycyrrhizae 9g and Radix Aucklandiae 5g.
Embodiment 3
A kind of Chinese medicine composition for the treatment of chronic gastritis, its raw material of Chinese medicine and weight proportion are: Radix Codonopsis 40g, Poria 10g, Rhizoma Atractylodis Macrocephalae 40g, Fructus Amomi 5g, Rhizoma Cyperi 15g, Radix Et Rhizoma Rhei 5g, Endoconcha Sepiae 30g, Radix Linderae 5g, Fructus Aurantii 20g, Fructus Citri Sarcodactylis 20g, Bulbus Lilii 20g, Radix Platycodonis 15g, Herba Taraxaci 10g, Cortex Magnoliae Officinalis 15g, Rhizoma Dioscoreae 20g, Rhizoma Corydalis 30g, Rhizoma Pinelliae 5g, Pericarpium Citri Reticulatae 15g, Radix Glycyrrhizae 5g and Radix Aucklandiae 15g.
Embodiment 4
A kind of Chinese medicine composition for the treatment of chronic gastritis, its raw material of Chinese medicine and weight proportion are: Radix Codonopsis 25g, Poria 25g, Rhizoma Atractylodis Macrocephalae 25g, Fructus Amomi 13g, Rhizoma Cyperi 8g, Radix Et Rhizoma Rhei 13g, Endoconcha Sepiae 15g, Radix Linderae 13g, Fructus Aurantii 12g, Fructus Citri Sarcodactylis 12g, Bulbus Lilii 35g, Radix Platycodonis 8g, Herba Taraxaci 25g, Cortex Magnoliae Officinalis 9g, Rhizoma Dioscoreae 35g, Rhizoma Corydalis 15g, Rhizoma Pinelliae 13g, Pericarpium Citri Reticulatae 7g, Radix Glycyrrhizae 10g and Radix Aucklandiae 8g.
Embodiment 5
A kind of Chinese medicine composition for the treatment of chronic gastritis, its raw material of Chinese medicine and weight proportion are: Radix Codonopsis 35g, Poria 15g, Rhizoma Atractylodis Macrocephalae 35g, Fructus Amomi 8g, Rhizoma Cyperi 13g, Radix Et Rhizoma Rhei 8g, Endoconcha Sepiae 25g, Radix Linderae 8g, Fructus Aurantii 18g, Fructus Citri Sarcodactylis 18g, Bulbus Lilii 25g, Radix Platycodonis 13g, Herba Taraxaci 15g, Cortex Magnoliae Officinalis 13g, Rhizoma Dioscoreae 25g, Rhizoma Corydalis 25g, Rhizoma Pinelliae 8g, Pericarpium Citri Reticulatae 13g, Radix Glycyrrhizae 8g and Radix Aucklandiae 13g.
Chinese medicine composition in embodiment of the invention decocting method is routinely produced medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, add cold water and cover powder, soaked 15～20 minutes, add water again and do not have about 6 centimetres of powder, carry out the decoction first time, at a simmer the preceding intense fire that adopts decocts, and slow fire boiling 20～30 minutes are used in the back of boiling; Second decocts, and adds water and does not have about 6 centimetres of powder, decocts 15～20 minutes after water boils.Twice decoction extracting juice that removes slag merges.
The present invention does clinical efficacy and is summarized as follows with the given a kind of Chinese medicine composition for the treatment of chronic gastritis of embodiment 1:
One, general data: Chinese medicine composition of the present invention is applied to clinical observation case 50 examples, male 25 examples wherein, women 25 examples, 20～70 years old age.The shortest person of the course of disease 4 months, elder reaches 2 years, average 0.5 year.
Two, diagnostic criteria:
(1) superficial gastritis
1, asymptomatic or upper abdominal pain, glutted, belch, decreased food intake etc. are arranged, idol has upper gastrointestinal hemorrhage;
2, x-ray barium meal examination lacks positive sign;
3, gastric analysis: gastric acid is normal or high slightly;
4. endoscopy is seen mucosa (reddish tint is main) red and white, and edema has thick, sticky mucus to adhere to, and can have rotten to the corn and hemorrhage; The mucosa biopsy is the shallow-layer inflammatory cell infiltration, and body of gland is normal;
(2) atrophic gastritis typing standard is as follows:
1, body of stomach gastritis (A type): pathological changes is at body of stomach, diffusivity; Gastric acid lacks as or obviously lowers; Serum gastrin raises; Parietal cell antibodies (PCA) etc. are most positive; IFA can be positive, can merge pernicious anemia;
2, gastric antrum gastritis (Type B): pathological changes can be involved body, kitchen range mainly at gastric antrum; Gastric acid is normal or lower slightly; Serum gastrin is normal; BCA, PCA may be positive, but canceration (＜4%).Microscopy: can make a definite diagnosis, pathological changes can be confined to body of stomach or gastric antrum portion, but also disperse; Mucosa is greyish white or red and white (Bai Xiangwei master), and pleat attenuates, the mucosa attenuation, and blood vessel is seen thoroughly under the mucosa; Sometimes gland nest hypertrophy, local mucous membrane thickening are graininess and change (cross and form).The holostrome cell infiltration is seen in the mucosa biopsy, and big of body of gland disappears or complete obiteration (gastratrophia), and generation, severe patient had atypical hyperplasia with intestinal gland metaplasia or pylorus glandular metaplasia.
Three, usage and dosage: during clinical practice, the component in the compositions, consumption are taken the circumstances into consideration increase and decrease according to patient's body weight, age and symptom.One day potion, the about 300ml of twice extracting juice of decocting, divide early, late twice half an hour ante cibum warm taking.Period in a medicine avoids eating anything raw or cold, pungent thing.
Four, criterion of therapeutical effect:
(1), cure: clinical cardinal symptom and sign disappear, and chronic inflammatory disease is pass on well slightly;
(2), take a turn for the better: clinical cardinal symptom disappears, and minor symptom disappears substantially, and chronic inflammatory disease takes a turn for the better;
(3), invalid; The cardinal symptom no change does not worsen yet.
Five, therapeutic effect: in this clinical observation case, took medicine 5-30 days, cure 30 examples, 15 examples that take a turn for the better, 5 examples do not heal.Toxic and side effects does not take place during the treatment.
Six, model case:
Case 1:
Liu, the woman, 42 years old, it is surplus that readme suffers from chronic atrophic gastritis 2 years, abdominal distention, the uncomfortable companion of epigastrium dull pain belch return acid, heartburn sense recently, stool once a day, the self-induction stool is not smooth.Take the medicament of Chinese medicine composition preparation of the present invention after 7 days, abdominal distention, stomachache alleviate slightly behind the conscious medicine, heartburn, acid regurgitation do not occur; After continuing to take 5 days, abdominal distention, stomachache not obvious; Diet increases, and is comfortable in the stomach of food back, no singultus, heartburn, acid regurgitation symptom; Continue to strengthen and take 5 days, cure.
Case 2:
Zhang, the man, 50 years old, normal upper abdomen and the upper abdomen paroxysmal pain that takes over down, pain increases the weight of when unhappy, and diet is poor, with feeling sick, detests oil, and the half a year of suffering from diarrhoea is surplus, looks into through gastroscope to be diagnosed as: chronic gastritis.Take the medicament 5 days of Chinese medicine composition of the present invention preparation, food is received and is become good, and paroxysmal pain, diarrhoea number of times reduce; Continuous clothes 7 days, paroxysmal pain, diarrhoea all disappear, and every day, defecation was 1 time, and feces is normal; Continue to strengthen and take 3 days, cure.
Claims (2)
1. Chinese medicine composition for the treatment of chronic gastritis, it is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: Radix Codonopsis 10-40 part, Poria 10-30 part, Rhizoma Atractylodis Macrocephalae 10-40 part, Fructus Amomi 5-15 part, Rhizoma Cyperi 5-15 part, Radix Et Rhizoma Rhei 5-15 part, Endoconcha Sepiae 10-30 part, Radix Linderae 5-15 part, Fructus Aurantii 10-20 part, Fructus Citri Sarcodactylis 10-20 part, Bulbus Lilii 20-40 part, Radix Platycodonis 5-15 part, Herba Taraxaci 10-30 part, Cortex Magnoliae Officinalis 5-15 part, Rhizoma Dioscoreae 10-40 part, Rhizoma Corydalis 10-30 part, Rhizoma Pinelliae 5-15 part, Pericarpium Citri Reticulatae 5-15 part, Radix Glycyrrhizae 5-10 part and Radix Aucklandiae 5-15 part.
2. a kind of Chinese medicine composition for the treatment of chronic gastritis according to claim 1, it is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: 10 parts of 30 parts of Radix Codonopsis, 20 parts in Poria, 30 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of Fructus Amomis, 10 parts of Rhizoma Cyperis, 10 parts of Radix Et Rhizoma Rhei, 20 parts of Endoconcha Sepiaes, 10 parts of the Radixs Linderae, 15 parts of Fructus Aurantiis, 15 parts of Fructus Citri Sarcodactylis, 30 parts of Bulbus Liliies, 10 parts of Radix Platycodoniss, 20 parts of Herba Taraxacis, 10 parts of Cortex Magnoliae Officinalis, 30 parts of Rhizoma Dioscoreaes, 20 parts of Rhizoma Corydalis, 10 parts of the Rhizoma Pinelliaes, 10 parts of Pericarpium Citri Reticulataes, 6 parts in Radix Glycyrrhizae and the Radix Aucklandiae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310261168.3A CN103341113B (en) | 2013-06-27 | 2013-06-27 | Chinese medicine composition for treating chronic gastritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310261168.3A CN103341113B (en) | 2013-06-27 | 2013-06-27 | Chinese medicine composition for treating chronic gastritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103341113A true CN103341113A (en) | 2013-10-09 |
| CN103341113B CN103341113B (en) | 2015-02-18 |
Family
ID=49275973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310261168.3A Expired - Fee Related CN103341113B (en) | 2013-06-27 | 2013-06-27 | Chinese medicine composition for treating chronic gastritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103341113B (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103637122A (en) * | 2013-12-11 | 2014-03-19 | 罗永祺 | Chewable tablet of tuckahoe and Chinese yam and preparation method thereof |
| CN104013895A (en) * | 2014-05-20 | 2014-09-03 | 柳晖 | Traditional Chinese medicine composition for treating epigastric pain caused by duodenal ulcer |
| CN104107387A (en) * | 2014-07-24 | 2014-10-22 | 王浩 | Traditional Chinese medicinal composition for treating chronic gastritis |
| CN104587351A (en) * | 2015-02-15 | 2015-05-06 | 赵世明 | Traditional Chinese medicine composition for treating chronic gastroenteritis |
| CN104667126A (en) * | 2015-02-15 | 2015-06-03 | 柳晖 | Traditional Chinese medicinal composition for treating chronic gastritis |
| CN104784617A (en) * | 2015-04-08 | 2015-07-22 | 山东昊福药业集团制药有限公司 | Compound traditional Chinese medicine preparation for treating enterogastritis and preparation method thereof |
| CN105125784A (en) * | 2015-09-11 | 2015-12-09 | 李传义 | Traditional Chinese medicine for regulating qi and preparation method thereof |
| CN105816622A (en) * | 2016-04-01 | 2016-08-03 | 蔡兵兵 | Traditional Chinese medicinal composition for treating chronic gastritis |
| CN108721504A (en) * | 2017-04-22 | 2018-11-02 | 邓泽潭 | A kind of traditional Chinese medicine for oral administration for treating chronic gastritis |
| CN109248272A (en) * | 2017-07-16 | 2019-01-22 | 邓泽潭 | A kind of oral traditional Chinese medicine composition for treating chronic gastritis |
| CN111759979A (en) * | 2020-07-27 | 2020-10-13 | 杨波 | Traditional Chinese medicine formula for treating chronic gastritis and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1919331A (en) * | 2006-08-22 | 2007-02-28 | 夏金陵 | Chinese medicine composition for treating gastritis and preparing method thereof |
| CN101138616A (en) * | 2007-09-08 | 2008-03-12 | 门连社 | Prescription for treating tummy bug |
| CN102091282A (en) * | 2011-03-25 | 2011-06-15 | 路正平 | Medicament for treating chronic gastritis and gastric ulcer |
-
2013
- 2013-06-27 CN CN201310261168.3A patent/CN103341113B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1919331A (en) * | 2006-08-22 | 2007-02-28 | 夏金陵 | Chinese medicine composition for treating gastritis and preparing method thereof |
| CN101138616A (en) * | 2007-09-08 | 2008-03-12 | 门连社 | Prescription for treating tummy bug |
| CN102091282A (en) * | 2011-03-25 | 2011-06-15 | 路正平 | Medicament for treating chronic gastritis and gastric ulcer |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103637122A (en) * | 2013-12-11 | 2014-03-19 | 罗永祺 | Chewable tablet of tuckahoe and Chinese yam and preparation method thereof |
| CN104013895A (en) * | 2014-05-20 | 2014-09-03 | 柳晖 | Traditional Chinese medicine composition for treating epigastric pain caused by duodenal ulcer |
| CN104107387A (en) * | 2014-07-24 | 2014-10-22 | 王浩 | Traditional Chinese medicinal composition for treating chronic gastritis |
| CN104587351A (en) * | 2015-02-15 | 2015-05-06 | 赵世明 | Traditional Chinese medicine composition for treating chronic gastroenteritis |
| CN104667126A (en) * | 2015-02-15 | 2015-06-03 | 柳晖 | Traditional Chinese medicinal composition for treating chronic gastritis |
| CN104784617A (en) * | 2015-04-08 | 2015-07-22 | 山东昊福药业集团制药有限公司 | Compound traditional Chinese medicine preparation for treating enterogastritis and preparation method thereof |
| CN104784617B (en) * | 2015-04-08 | 2018-04-06 | 山东昊福药业集团制药有限公司 | A kind of compound Chinese medicinal preparation for treating enterogastritis and preparation method thereof |
| CN105125784A (en) * | 2015-09-11 | 2015-12-09 | 李传义 | Traditional Chinese medicine for regulating qi and preparation method thereof |
| CN105816622A (en) * | 2016-04-01 | 2016-08-03 | 蔡兵兵 | Traditional Chinese medicinal composition for treating chronic gastritis |
| CN108721504A (en) * | 2017-04-22 | 2018-11-02 | 邓泽潭 | A kind of traditional Chinese medicine for oral administration for treating chronic gastritis |
| CN109248272A (en) * | 2017-07-16 | 2019-01-22 | 邓泽潭 | A kind of oral traditional Chinese medicine composition for treating chronic gastritis |
| CN111759979A (en) * | 2020-07-27 | 2020-10-13 | 杨波 | Traditional Chinese medicine formula for treating chronic gastritis and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103341113B (en) | 2015-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103341113B (en) | Chinese medicine composition for treating chronic gastritis | |
| CN103316279B (en) | Traditional Chinese medicine composition for treating chronic gastroenteritis | |
| CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN104107387A (en) | Traditional Chinese medicinal composition for treating chronic gastritis | |
| CN103463587A (en) | Traditional Chinese medicine composition for treating deficiency-cold in spleen and stomach | |
| CN103394057B (en) | Traditional Chinese medicine composition for treating diarrhoea | |
| CN102430106B (en) | Traditional Chinese medicine composite for treating stomachache | |
| CN104771707A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN103272143B (en) | Traditional Chinese medicine composition for treating acne | |
| CN103550687B (en) | A kind of Chinese medicine composition for the treatment of the hepatic and renal YIN deficiency | |
| CN102430104B (en) | Traditional Chinese medicine composite for treating epigastric pain | |
| CN103330914B (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN103316317A (en) | Traditional Chinese medicine composition for treating superficial gastritis | |
| CN103550661A (en) | Chinese medicinal composition for treating stomach cold and stomachache | |
| CN102430105B (en) | Traditional Chinese medicine composite for treating chronic gastritis | |
| CN104667126A (en) | Traditional Chinese medicinal composition for treating chronic gastritis | |
| CN104771657A (en) | Traditional Chinese medicine composition for treating gastric ulcer | |
| CN103550690B (en) | A kind of Chinese medicine composition for the treatment of superficial gastritis | |
| CN103212013B (en) | Chinese medicinal composition for treating epigastric pain | |
| CN104623544A (en) | Traditional Chinese medicine preparation capable of tonifying spleen and eliminating dampness for treating moderate fatty liver and preparation method of traditional Chinese medicine preparation | |
| CN104352675A (en) | Traditional Chinese medicine oral decoction for treating paediatrical odontoprisis | |
| CN103800836B (en) | A kind of stagnant heat in the liver and gall for the treatment of causes the Chinese medicine composition having loose bowels | |
| CN103800835A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN102512622B (en) | Chinese medicine composition for treating stomachache of damp and hot accumulation sluggish | |
| CN104013895A (en) | Traditional Chinese medicine composition for treating epigastric pain caused by duodenal ulcer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150218 Termination date: 20150627 |
|
| EXPY | Termination of patent right or utility model |